JSON
Wasik AM, Wu C, Mansouri L, Rosenquist R, Pan-Hammarström Q, Sander B
Blood Adv 2 (6) 621-625 [2018-03-27; online 2018-03-20]
S1PR1 mutations are present in 7.8% of patients with MCL and are significantly more frequent at relapse. S1PR1 mutations reduce expression of the S1PR1 receptor, which mediates migration towards the tissue-to-blood egress factor S1P in MCL. .
PubMed 29549086
DOI 10.1182/bloodadvances.2017014860
Crossref 10.1182/bloodadvances.2017014860
pmc: PMC5873236
pii: bloodadvances.2017014860